{
    "Trade/Device Name(s)": [
        "i-STAT BNP test",
        "i-STAT BNP Control Level 1",
        "i-STAT BNP Control Level 2",
        "i-STAT BNP Control Level 3",
        "i-STAT BNP Calibration Verification Control Set"
    ],
    "Submitter Information": "i-STAT Corporation",
    "510(k) Number": "K053597",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBC",
        "JJX"
    ],
    "Summary Letter Date": "July 21, 2006",
    "Summary Letter Received Date": "June 15, 2006",
    "Submission Date": "June 14, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1117",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "B-type natriuretic peptide test system",
        "Single (Specified) Analyte Controls (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "cardiology",
        "POCT"
    ],
    "Analyte(s)": [
        "B-type Natriuretic Peptide (BNP)"
    ],
    "Specimen Type(s)": [
        "Whole blood",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "i-STAT 1 Analyzer (Immuno symbol)"
    ],
    "Method(s)/Technology(ies)": [
        "Two-site ELISA",
        "Enzyme immunoassay",
        "Electrochemical detection"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Calibrator",
        "Control",
        "Verification kit"
    ],
    "Document Summary": "FDA 510(k) summary for i-STAT BNP Test and associated controls and calibration verification controls for quantitative BNP measurement using immunoassay on i-STAT 1 Analyzer.",
    "Indications for Use Summary": "In vitro diagnostic test for the quantitative measurement of B-Type Natriuretic Peptide (BNP) in whole blood or plasma (EDTA) as an aid in the diagnosis and assessment of severity of congestive heart failure.",
    "fda_folder": "Clinical Chemistry"
}